Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 09:46 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 24, 2026 08:37 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer

Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting...
March 23, 2026 18:49 ET | Source: The Rosen Law Firm PA

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and...
March 23, 2026 18:10 ET | Source: The Rosen Law Firm PA

FIVN Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Five9, Inc. – FIVN

NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential breaches of fiduciary duties by the directors and officers of...
March 23, 2026 16:51 ET | Source: Faruqi & Faruqi LLP

ATRA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Atara Biotherapeutics (ATRA) Investors of Securities Class Action Deadline on May 22, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Atara To Contact Him Directly To Discuss Their Options If you purchased or...
March 23, 2026 08:05 ET | Source: OwlTing Group

OwlTing Group (NASDAQ: OWLS) Recognized Among Financial Times Top 500 High-Growth Companies in Asia-Pacific 2026

OwlTing Group (NASDAQ: OWLS) ranks No. 226 on Financial Times High-Growth Companies Asia-Pacific 2026, with 42% CAGR and 189% revenue growth (2021–2024).
March 23, 2026 05:01 ET | Source: Trifork Group AG

20/2026・Trifork Group: Weekly report on share buyback

Schindellegi, Switzerland – 23 March 2026 Trifork Group AGCompany announcement no. 20/2026 Weekly report on share buyback On 27 February 2026, Trifork initiated a share buyback program in...
March 22, 2026 20:05 ET | Source: The Rosen Law Firm PA

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of...
March 22, 2026 19:33 ET | Source: The Rosen Law Firm PA

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Eos Energy Enterprises, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EOSE

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Eos Energy Enterprises, Inc. (NASDAQ: EOSE) between...
March 22, 2026 08:00 ET | Source: The Rosen Law Firm PA

MREO DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

NEW YORK, March 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Mereo BioPharma Group plc (NASDAQ:...